Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives
Authors:
Open Access
- 1 July 2016
- journal article
- review article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 131 (3) , 155-161
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Guidelines for the Management of Spontaneous Intracerebral HemorrhageStroke, 2015
- Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysisJournal of Stroke and Cerebrovascular Diseases, 2015
- Development, maintenance and disruption of the blood-brain barrierNature Medicine, 2013
- Cilostazol, Not Aspirin, Reduces Ischemic Brain Injury via Endothelial Protection in Spontaneously Hypertensive RatsStroke, 2011
- Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trialThe Lancet Neurology, 2010
- Is Platelet Activity Important in Acute Intracerebral Hemorrhage?Neurocritical Care, 2009
- Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damageNeuroscience Letters, 2009
- Cilostazol Inhibits Oxidative Stress–Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative DisordersNeuron, 2008
- Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO productionMicrovascular Research, 2004